We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$4.27B
AUM Growth
-$156M
Cap. Flow
-$259M
Cap. Flow %
-6.06%
Top 10 Hldgs %
15.28%
Holding
747
New
35
Increased
227
Reduced
378
Closed
43

Sector Composition

Rank Sector Weight
1 Technology 20.24%
2 Healthcare 12.82%
3 Communication Services 12.03%
4 Industrials 11.98%
5 Financials 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQUA
51
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$22.9M 0.54%
1,605,562
+245,477
+18% +$3.19M
PG icon
52
Procter & Gamble
PG
$340B
$22.7M 0.53%
206,793
-3,671
-2% -$391K
INTC icon
53
Intel
INTC
$413B
$22.1M 0.52%
461,119
-47,817
-9% -$2.37M
AMZN icon
54
Amazon
AMZN
$2.44T
$21.6M 0.51%
227,860
+5,600
+3% +$522K
QQQ icon
55
Invesco QQQ Trust
QQQ
$436B
$21.4M 0.5%
114,531
-3,043
-3% -$560K
MDCO
56
DELISTED
Medicines Co
MDCO
$20.4M 0.48%
559,500
-150,492
-21% -$4.91M
WERN icon
57
Werner Enterprises
WERN
$2.2B
$20.2M 0.47%
651,085
-62,682
-9% -$2.02M
BAC icon
58
Bank of America
BAC
$429B
$19.4M 0.45%
667,805
-9,182
-1% -$265K
GOOG icon
59
Alphabet (Google) Class C
GOOG
$4.11T
$19.4M 0.45%
358,100
+55,340
+18% +$3.19M
VZ icon
60
Verizon
VZ
$197B
$18.8M 0.44%
328,795
-9,516
-3% -$548K
COHR icon
61
Coherent
COHR
$43.4B
$18.3M 0.43%
499,169
-48,464
-9% -$1.77M
LAZ icon
62
Lazard
LAZ
$3.96B
$18.2M 0.43%
529,737
-22,553
-4% -$808K
XOM icon
63
ExxonMobil
XOM
$650B
$18M 0.42%
234,867
+1,880
+0.8% +$146K
ONCE
64
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$17.6M 0.41%
171,985
-17,121
-9% -$1.85M
SCZ icon
65
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.1B
$17.6M 0.41%
306,657
+224
+0.1% +$12.9K
CUB
66
DELISTED
Cubic Corporation
CUB
$16.6M 0.39%
258,097
+115,566
+81% +$6.79M
SRPT icon
67
Sarepta Therapeutics
SRPT
$1.64B
$16.5M 0.39%
108,641
-86,766
-44% -$10.5M
FORM icon
68
FormFactor
FORM
$6.51B
$16.5M 0.39%
1,050,055
-97,835
-9% -$1.6M
AVAV icon
69
AeroVironment
AVAV
$7.19B
$16.4M 0.38%
289,518
-20,191
-7% -$1.33M
FNSR
70
DELISTED
Finisar Corp
FNSR
$16.2M 0.38%
709,344
-59,094
-8% -$1.35M
HP icon
71
Helmerich & Payne
HP
$3.34B
$16.2M 0.38%
320,077
-22,630
-7% -$1.25M
VEA icon
72
Vanguard FTSE Developed Markets ETF
VEA
$223B
$16.2M 0.38%
388,398
-1,129
-0.3% -$46.5K
VIAV icon
73
Viavi Solutions
VIAV
$7.95B
$15.8M 0.37%
1,186,698
-112,582
-9% -$1.46M
GOOGL icon
74
Alphabet (Google) Class A
GOOGL
$4.12T
$15.7M 0.37%
290,820
+18,260
+7% +$1.06M
KYNB
75
Kyntra Bio
KYNB
$27.4M
$15.6M 0.37%
13,815
-1,154
-8% -$1.26M

Similar funds

Pinnacle Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Pinnacle Associates held 747 positions worth $4.27B, down 3.5% from $4.43B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Pinnacle Associates withdrew a net $259M in Q2 2019, closing 43 positions and reducing 378 holdings. Its most notable exit was ARRIS International plc Ordinary Shares, an estimated $29.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Pinnacle Associates opened a new position in Dow Inc worth $5.76M.

  • Pinnacle Associates's largest Q2 2019 buy was Dow Inc: 116,842 shares worth $5.76M.
  • Pinnacle Associates added most to Constellation Brands in Q2 2019, an estimated $7.1M increase.
  • Pinnacle Associates's biggest Q2 2019 reduction was Array Biopharma Inc, cutting an estimated $26.5M.
  • Pinnacle Associates fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $29.4M.
  • Pinnacle Associates's ten largest holdings make up 15% of its $4.27B portfolio in Q2 2019.
  • Pinnacle Associates opened 35 new positions and closed 43 in Q2 2019.
  • Pinnacle Associates's portfolio value fell 3.5% quarter-over-quarter to $4.27B.

Based on Pinnacle Associates's 13F filing for Q2 2019, filed 5 Aug 2019.